Skip to content

Virtual Reality treatment for improving SOcial functioning and Participation

Virtual Reality treatment for improving SOcial functioning and Participation of young people with psychosis: a pilot study.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON21243
Enrollment
6
Registered
2020-06-29
Start date
2020-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychosis (psychotic disorder).

Interventions

VR-SOAP consists of 14 weekly sessions (60 minutes) focused on enhancing the quantity and quality of social contacts, leisure activities and participation of young people with a psychotic disorder. VR

Sponsors

University Medical Center Groningen (Hanzeplein 1, 9713 GZ Groningen).
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: DSM-5 diagnosis of schizophrenia spectrum or other psychotic disorder (1). Reduced quantity or quality of social contacts, leisure activities or social participation, according to treating clinician and/or patient (2). Age 18-35 (3).

Exclusion criteria

Exclusion criteria: Estimated IQ ?70, according to the treating clinician (1). Insufficient command of the Dutch language (2). (Photosensitive) epilepsy (3).

Design outcomes

Primary

MeasureTime frame
Feasibility and acceptability of the therapy (flow chart including the amount of patients that were invited to participate, the amount of patients that decided to participate, and reasons for not participating, drop-out and adherence rates). Also input from therapists and participants (questions about the length of sessions, order and structure of modules, exercises, time spent in VR, acceptability, process of change, barriers and suggestions for further improvement etc.).

Secondary

MeasureTime frame
Sensitivity to change of suitable outcome measures: quantity and quality of social contacts, (leisure) activities and participation in daily life (measured with Experience Sampling Method [ESM]), level of functioning and determinants of social interaction difficulties (measured with questionnaires and interviews).

Contacts

Public ContactDauw Catharina Muijsson

University Medical Center Groningen (UMCG)

d.c.muijsson@umcg.nl050 - 3615114

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)